样式: 排序: IF: - GO 导出 标记为已读
-
Dual inheritance patterns: A spectrum of non-syndromic inherited retinal disease phenotypes with varying molecular mechanisms Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-10-31 Lara K. Holtes, Suzanne E. de Bruijn, Frans P.M. Cremers, Susanne Roosing
Inherited retinal diseases (IRDs) encompass a variety of disease phenotypes and are known to display both clinical and genetic heterogeneity. A further complexity is that for several IRD-associated genes, pathogenic variants have been reported to cause either autosomal dominant (AD) or autosomal recessive (AR) diseases. The possibility of dual inheritance can create a challenge for variant interpretation
-
Eye on the horizon: The metabolic landscape of the RPE in aging and disease Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-10-19 David S. Hansman, Jianhai Du, Robert J. Casson, Daniel J. Peet
To meet the prodigious bioenergetic demands of the photoreceptors, glucose and other nutrients must traverse the retinal pigment epithelium (RPE), a polarised monolayer of cells that lie at the interface between the outer retina and the choroid, the principal vascular layer of the eye. Recent investigations have revealed a metabolic ecosystem in the outer retina where the photoreceptors and RPE engage
-
Pathobiology of the crystalline lens in Stickler syndrome Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-09-29 Martin P. Snead, Frank J. Lovicu, Thomas RW. Nixon, Allan J. Richards, Howard Martin
The Stickler syndromes are a group of connective tissue disorders characterised by congenital myopia, giant retinal tear and retinal detachment, cleft palate, hearing loss and premature arthropathy. Patients with Stickler syndrome are also susceptible to abnormalities of the crystalline lens. Since neither type II or type XI collagen (those typically affected in the vast majority of Stickler patients)
-
AI in the clinical management of GA: A novel therapeutic universe requires novel tools Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-09-27 Gregor S. Reiter, Julia Mai, Sophie Riedl, Klaudia Birner, Sophie Frank, Hrvoje Bogunovic, Ursula Schmidt-Erfurth
Regulatory approval of the first two therapeutic substances for the management of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) is a major breakthrough following failure of numerous previous trials. However, in the absence of therapeutic standards, diagnostic tools are a key challenge as functional parameters in GA are hard to provide. The majority of anatomical biomarkers
-
The relationship between intraocular pressure and glaucoma: An evolving concept Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-09-19 Sanjay G. Asrani, Elyse J. McGlumphy, Lama A. Al-Aswad, Craig J. Chaya, Shan Lin, David C. Musch, Ian Pitha, Alan L. Robin, Barbara Wirostko, Thomas V. Johnson
Intraocular pressure (IOP) is the most important modifiable risk factor for glaucoma and fluctuates considerably within patients over short and long time periods. Our field's understanding of IOP has evolved considerably in recent years, driven by tonometric technologies with increasing accuracy, reproducibility, and temporal resolution that have refined our knowledge regarding the relationship between
-
Ocular adverse events associated with antibody-drug conjugates used in cancer: Focus on pathophysiology and management strategies Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-09-18 Eric E. Gabison, Antoine Rousseau, Marc Labetoulle, Anas Gazzah, Benjamin Besse
Antibody-drug conjugates (ADCs) are designed to maximize cancer cell death with lower cytotoxicity toward noncancerous cells and are an increasingly valuable option for targeted cancer therapies. However, anticancer treatment with ADCs may be associated with ocular adverse events (AEs) such as dry eye, conjunctivitis, photophobia, blurred vision, and corneal abnormalities. While the pathophysiology
-
The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-09-06 Elena K. Schneider-Futschik, Yimin Zhu, Danni Li, Mark D. Habgood, Bao N. Nguyen, Ines Pankonien, Margarida D. Amaral, Laura E. Downie, Holly R. Chinnery
Cystic fibrosis transmembrane conductance regulator (CFTR) is a protein that plays a crucial role in various human organs, including the respiratory and digestive systems. Dysfunctional CFTR is the key variant of the lethal genetic disorder, cystic fibrosis (CF). In the past decade, highly effective CFTR modulator therapies, including elexacaftor-tezacaftor-ivacaftor, have revolutionised CF management
-
Optical coherence tomography angiography of the retina and choroid in systemic diseases Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-08-30 Jacqueline Chua, Bingyao Tan, Damon Wong, Gerhard Garhöfer, Xin Wei Liew, Alina Popa-Cherecheanu, Calvin Woon Loong Chin, Dan Milea, Christopher Li-Hsian Chen, Leopold Schmetterer
Optical coherence tomography angiography (OCTA) has transformed ocular vascular imaging, revealing microvascular changes linked to various systemic diseases. This review explores its applications in diabetes, hypertension, cardiovascular diseases, and neurodegenerative diseases. While OCTA provides a valuable window into the body's microvasculature, interpreting the findings can be complex. Additionally
-
The AI revolution in glaucoma: Bridging challenges with opportunities Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-08-24 Fei Li, Deming Wang, Zefeng Yang, Yinhang Zhang, Jiaxuan Jiang, Xiaoyi Liu, Kangjie Kong, Fengqi Zhou, Clement C. Tham, Felipe Medeiros, Ying Han, Andrzej Grzybowski, Linda M. Zangwill, Dennis S.C. Lam, Xiulan Zhang
Recent advancements in artificial intelligence (AI) herald transformative potentials for reshaping glaucoma clinical management, improving screening efficacy, sharpening diagnosis precision, and refining the detection of disease progression. However, incorporating AI into healthcare usages faces significant hurdles in terms of developing algorithms and putting them into practice. When creating algorithms
-
Value proposition of retinal imaging in Alzheimer's disease screening: A review of eight evolving trends Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-08-22 Victor T.T. Chan, An Ran Ran, Siegfried K. Wagner, Herbert Y.H. Hui, Xiaoyan Hu, Ho Ko, Sharon Fekrat, Yaxing Wang, Cecilia S. Lee, Alvin L. Young, Clement C. Tham, Yih Chung Tham, Pearse A. Keane, Dan Milea, Christopher Chen, Tien Yin Wong, Vincent C.T. Mok, Carol Y. Cheung
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Current diagnostic modalities of AD generally focus on detecting the presence of amyloid β and tau protein in the brain (for example, positron emission tomography [PET] and cerebrospinal fluid testing), but these are limited by their high cost, invasiveness, and lack of expertise. Retinal imaging exhibits potential in AD screening
-
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-08-08 Benjamin WJ. Ng, Maria K. Kaukonen, Michelle E. McClements, Hoda Shamsnajafabadi, Robert E. MacLaren, Jasmina Cehajic-Kapetanovic
Conventional gene therapy involving supplementation only treats loss-of-function diseases and is limited by viral packaging sizes, precluding therapy of large genes. The discovery of CRISPR/Cas has led to a paradigm shift in the field of genetic therapy, with the promise of precise gene editing, thus broadening the range of diseases that can be treated. The initial uses of CRISPR/Cas have focused mainly
-
Congenital anterior segment ocular disorders: Genotype-phenotype correlations and emerging novel mechanisms Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-08-02 Linda M. Reis, Sarah E. Seese, Deborah Costakos, Elena V. Semina
Development of the anterior segment of the eye requires reciprocal sequential interactions between the arising tissues, facilitated by numerous genetic factors. Disruption of any of these processes results in congenital anomalies in the affected tissue(s) leading to anterior segment disorders (ASD) including aniridia, Axenfeld-Rieger anomaly, congenital corneal opacities (Peters anomaly, cornea plana
-
In vitro and ex vivo models of microbial keratitis: Present and future Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-07-14 Kelvin Kah Wai Cheng, Leonie Fingerhut, Sheelagh Duncan, N. Venkatesh Prajna, Adriano G. Rossi, Bethany Mills
Microbial keratitis (MK) is an infection of the cornea, caused by bacteria, fungi, parasites, or viruses. MK leads to significant morbidity, being the fifth leading cause of blindness worldwide. There is an urgent requirement to better understand pathogenesis in order to develop novel diagnostic and therapeutic approaches to improve patient outcomes. Many and MK models have been developed and implemented
-
Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-07-03 Gink N. Yang, Yu B.Y. Sun, Philip Ke Roberts, Hothri Moka, Min K. Sung, Jesse Gardner-Russell, Layal El Wazan, Bridget Toussaint, Satheesh Kumar, Heather Machin, Gregory J. Dusting, Geraint J. Parfitt, Kathryn Davidson, Elaine W. Chong, Karl D. Brown, Jose M. Polo, Mark Daniell
Single-cell RNA sequencing (scRNA-seq) has enabled the identification of novel gene signatures and cell heterogeneity in numerous tissues and diseases. Here we review the use of this technology for Fuchs’ Endothelial Corneal Dystrophy (FECD). FECD is the most common indication for corneal endothelial transplantation worldwide. FECD is challenging to manage because it is genetically heterogenous, can
-
Ocular manifestations of COVID-19 Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-06-24 Hannah W. Ng, Daniel A.R. Scott, Helen V. Danesh-Meyer, Justine R. Smith, Charles NJ. McGhee, Rachael L. Niederer
There is an increasing body of knowledge regarding how COVID-19 may be associated with ocular disease of varying severity and duration. This article discusses the literature on the ocular manifestations associated with COVID-19, including appraisal of the current evidence, suggested mechanisms of action, associated comorbidities and risk factors, timing from initial infection to diagnosis and clinical
-
Crosslinking with UV-A and riboflavin in progressive keratoconus: From laboratory to clinical practice – Developments over 25 years Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-06-01 Frederik Raiskup, Robert Herber, Janine Lenk, Lutz E. Pillunat, Eberhard Spoerl
Changes in the biomechanical and biochemical properties of the human cornea play an important role in the pathogenesis of ectatic diseases. A number of conditions in primarily acquired (keratoconus or pellucid marginal degeneration) or secondarily induced (iatrogenic keratectasia after refractive laser surgeries) ectatic disorders lead to decreased biomechanical stability. Corneal collagen cross-linking
-
Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-28 Kristina Pfau, Imre Lengyel, Jeannette Ossewaarde-van Norel, Redmer van Leeuwen, Sara Risseeuw, Georges Leftheriotis, Hendrik P.N. Scholl, Nicolas Feltgen, Frank G. Holz, Maximilian Pfau
Pseudoxanthoma elasticum (PXE) is an autosomal-recessively inherited multisystem disease. Mutations in the -gene are causative, coding for a transmembrane transporter mainly expressed in hepatocytes, which promotes the efflux of adenosine triphosphate (ATP). This results in low levels of plasma inorganic pyrophosphate (PPi), a critical anti-mineralization factor. The clinical phenotype of PXE is characterized
-
Cell therapy in the cornea: The emerging role of microenvironment Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-24 Giuseppe Suanno, Vincenzo Giuseppe Genna, Eleonora Maurizi, Anas Abu Dieh, May Griffith, Giulio Ferrari
-
Chromatic visual evoked potentials: A review of physiology, methods and clinical applications Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-16 Oliver R. Marmoy, Manca Tekavčič Pompe, Jan Kremers
Objective assessment of the visual system can be performed electrophysiologically using the visual evoked potential (VEP). In many clinical circumstances, this is performed using high contrast achromatic patterns or diffuse flash stimuli. These methods are clinically valuable but they may only assess a subset of possible physiological circuitries within the visual system, particularly those involved
-
Alzheimer's disease pathophysiology in the Retina Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-15 Bhakta Prasad Gaire, Yosef Koronyo, Dieu-Trang Fuchs, Haoshen Shi, Altan Rentsendorj, Ron Danziger, Jean-Philippe Vit, Nazanin Mirzaei, Jonah Doustar, Julia Sheyn, Harald Hampel, Andrea Vergallo, Miyah R. Davis, Ousman Jallow, Filippo Baldacci, Steven R. Verdooner, Ernesto Barron, Mehdi Mirzaei, Vivek K. Gupta, Stuart L. Graham, Mourad Tayebi, Roxana O. Carare, Alfredo A. Sadun, Carol A. Miller, Oana
The retina is an emerging CNS target for potential noninvasive diagnosis and tracking of Alzheimer's disease (AD). Studies have identified the pathological hallmarks of AD, including amyloid β-protein (Aβ) deposits and abnormal tau protein isoforms, in the retinas of AD patients and animal models. Moreover, structural and functional vascular abnormalities such as reduced blood flow, vascular Aβ deposition
-
Resilience to diabetic retinopathy Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-11 Anara Serikbaeva, Yanliang Li, Simon Ma, Darvin Yi, Andrius Kazlauskas
Chronic elevation of blood glucose at first causes relatively minor changes to the neural and vascular components of the retina. As the duration of hyperglycemia persists, the nature and extent of damage increases and becomes readily detectable. While this second, overt manifestation of diabetic retinopathy (DR) has been studied extensively, what prevents maximal damage from the very start of hyperglycemia
-
Mitochondrial retinopathies and optic neuropathies: The impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and management Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-05-03 Enrico Borrelli, Francesco Bandello, Camiel J.F. Boon, Valerio Carelli, Guy Lenaers, Michele Reibaldi, Srinivas R. Sadda, Alfredo A. Sadun, David Sarraf, Patrick Yu-Wai-Man, Piero Barboni
Advancements in ocular imaging have significantly broadened our comprehension of mitochondrial retinopathies and optic neuropathies by examining the structural and pathological aspects of the retina and optic nerve in these conditions. This article aims to review the prominent imaging characteristics associated with mitochondrial retinopathies and optic neuropathies, aiming to deepen our insight into
-
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-04-23 Yimeng Sun, Fan Li, Yunfei Liu, Dijie Qiao, Xinyu Yao, Guei-Sheung Liu, Dequan Li, Chuanle Xiao, Tao Wang, Wei Chi
Retinal diseases encompass various conditions associated with sight-threatening immune responses and are leading causes of blindness worldwide. These diseases include age-related macular degeneration, diabetic retinopathy, glaucoma and uveitis. Emerging evidence underscores the vital role of the innate immune response in retinal diseases, beyond the previously emphasized T-cell-driven processes of
-
Toward an internationally accepted standard for reading charts Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-04-02 Wolfgang Radner
Patients who suffer from sight-threatening eye diseases share a desire to regain a comfortable reading ability. In light of the modern advances achieved in ophthalmic diagnosis and therapy, and because a significant lack of comparability between reading charts still exists, there is an increasing need for a worldwide standard in the form of a norm for diagnostic reading charts. Already, applied advancements
-
Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-03-26 Ghazi O. Bou Ghanem, Lauren K. Wareham, David J. Calkins
Glaucoma is the leading cause of irreversible blindness globally. The disease causes vision loss due to neurodegeneration of the retinal ganglion cell (RGC) projection to the brain through the optic nerve. Glaucoma is associated with sensitivity to intraocular pressure (IOP). Thus, mainstay treatments seek to manage IOP, though many patients continue to lose vision. To address neurodegeneration directly
-
Glycative stress as a cause of macular degeneration Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-03-21 Eloy Bejarano, Alicia Domenech-Bendaña, Norma Avila-Portillo, Sheldon Rowan, Sachini Edirisinghe, Allen Taylor
People are living longer and rates of age-related diseases such as age-related macular degeneration (AMD) are accelerating, placing enormous burdens on patients and health care systems. The quality of carbohydrate foods consumed by an individual impacts health The glycemic index (GI) is a kinetic measure of the rate at which glucose arrives in the blood stream after consuming various carbohydrates
-
How gut microbiota may impact ocular surface homeostasis and related disorders Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-03-08 Marc Labetoulle, Christophe Baudouin, Jose M. Benitez del Castillo, Maurizio Rolando, Maria Rescigno, Elisabeth M. Messmer, Pasquale Aragona
Changes in the bacterial flora in the gut, also described as gut microbiota, are readily acknowledged to be associated with several systemic diseases, especially those with an inflammatory, neuronal, psychological or hormonal factor involved in the pathogenesis and/or the perception of the disease. Maintaining ocular surface homeostasis is also based on all these four factors, and there is accumulating
-
Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-03-01 Mandy Hector, Thomas Langmann, Anne Wolf
Translocator protein (18 kDa) (Tspo), formerly known as peripheral benzodiazepine receptor is a highly conserved transmembrane protein primarily located in the outer mitochondrial membrane. In the central nervous system (CNS), especially in glia cells, Tspo is upregulated upon inflammation. Consequently, Tspo was used as a tool for diagnostic imaging of neuroinflammation in the brain and as a potential
-
Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-02-16 Marzena Kurzawa-Akanbi, Nikolaos Tzoumas, Julio C. Corral-Serrano, Rosellina Guarascio, David H. Steel, Michael E. Cheetham, Lyle Armstrong, Majlinda Lako
-
Modeling complex age-related eye disease Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-02-15 Silke Becker, Zia L'Ecuyer, Bryan W. Jones, Moussa A. Zouache, Fiona S. McDonnell, Frans Vinberg
Modeling complex eye diseases like age-related macular degeneration (AMD) and glaucoma poses significant challenges, since these conditions depend highly on age-related changes that occur over several decades, with many contributing factors remaining unknown. Although both diseases exhibit a relatively high heritability of >50%, a large proportion of individuals carrying AMD- or glaucoma-associated
-
Central serous chorioretinopathy: An evidence-based treatment guideline Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-02-01 Helena M.A. Feenstra, Elon H.C. van Dijk, Chui Ming Gemmy Cheung, Kyoko Ohno-Matsui, Timothy Y.Y. Lai, Hideki Koizumi, Michael Larsen, Giuseppe Querques, Susan M. Downes, Suzanne Yzer, Mark P. Breazzano, Yousif Subhi, Ramin Tadayoni, Siegfried G. Priglinger, Laurenz J.B. Pauleikhoff, Clemens A.K. Lange, Anat Loewenstein, Roselie M.H. Diederen, Reinier O. Schlingemann, Carel B. Hoyng, Jay K. Chhablani
Central serous chorioretinopathy (CSC) is a relatively common disease that causes vision loss due to macular subretinal fluid leakage and it is often associated with reduced vision-related quality of life. In CSC, the leakage of subretinal fluid through defects in the retinal pigment epithelial layer's outer blood-retina barrier appears to occur secondary to choroidal abnormalities and dysfunction
-
Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-01-24 Michalis Georgiou, Anthony G. Robson, Kaoru Fujinami, Thales A.C. de Guimarães, Yu Fujinami-Yokokawa, Malena Daich Varela, Nikolas Pontikos, Angelos Kalitzeos, Omar A. Mahroo, Andrew R. Webster, Michel Michaelides
Inherited retinal diseases (IRD) are a leading cause of blindness in the working age population and in children. The scope of this review is to familiarise clinicians and scientists with the current landscape of molecular genetics, clinical phenotype, retinal imaging and therapeutic prospects/completed trials in IRD. Herein we present in a comprehensive and concise manner: (i) macular dystrophies (Stargardt
-
Optic neuropathy in high myopia: Glaucoma or high myopia or both? Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-01-21 Xiulan Zhang, Jingwen Jiang, Kangjie Kong, Fei Li, Shida Chen, Peiyuan Wang, Yunhe Song, Fengbin Lin, Timothy P.H. Lin, Linda M. Zangwill, Kyoko Ohno-Matsui, Jost B. Jonas, Robert N. Weinreb, Dennis S.C. Lam, Glaucoma Suspects with High Myopia Study Group
Due to the increasing prevalence of high myopia around the world, structural and functional damages to the optic nerve in high myopia has recently attracted much attention. Evidence has shown that high myopia is related to the development of glaucomatous or glaucoma-like optic neuropathy, and that both have many common features. These similarities often pose a diagnostic challenge that will affect
-
Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-01-17 Oren Tomkins-Netzer, Rachael Niederer, John Greenwood, Ido Didi Fabian, Yonatan Serlin, Alon Friedman, Sue Lightman
Blood-retinal barrier (BRB) disruption is a common accompaniment of intermediate, posterior and panuveitis causing leakage into the retina and macular oedema resulting in vision loss. It is much less common in anterior uveitis or in patients with intraocular lymphoma who may have marked signs of intraocular inflammation. New drugs used for chemotherapy (cytarabine, immune checkpoint inhibitors, BRAF
-
Investing in vision: Innovation in retinal therapeutics and the influence on venture capital investment Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-01-12 Dmitrij Hristodorov, Tim Lohoff, Nanna Luneborg, Geert-Jan Mulder, Simon J. Clark
Since the groundbreaking approval of the first anti-VEGF therapy in 2004, the retinal therapeutics field has undergone a remarkable transformation, witnessing a surge in novel, disease-modifying therapeutics for a broad spectrum of retinal diseases, extending beyond exudative VEGF-driven conditions. The surge in scientific advancement and the pressing, unmet, medical need have captured the attention
-
-
Punctate inner choroidopathy: A review of the current diagnostic and therapeutic approaches Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-01-03 Dimitrios Kalogeropoulos, Najiha Rahman, Farid Afshar, Nigel Hall, Andrew John Lotery
Punctate inner choroidopathy (PIC) is an uncommon idiopathic inflammatory condition characterized by multifocal chorioretinopathy that primarily affects young adults, with a predilection for myopic females. Clinically, it manifests as small, yellowish-white lesions in the inner choroid and outer retina, often associated with inflammatory changes. Accurate diagnosis remains a challenge due to its resemblance
-
Squishy matters – Corneal mechanobiology in health and disease Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2024-01-02 Sara M. Thomasy, Brian C. Leonard, Mark A. Greiner, Jessica M. Skeie, Vijay Krishna Raghunathan
The cornea, as a dynamic and responsive tissue, constantly interacts with mechanical forces in order to maintain its structural integrity, barrier function, transparency and refractive power. Cells within the cornea sense and respond to various mechanical forces that fundamentally regulate their morphology and fate in development, homeostasis and pathophysiology. Corneal cells also dynamically regulate
-
UVR and RPE – The Good, the Bad and the degenerate Macula Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-12-20 Graham Anderson, Shyamanga Borooah, Roly Megaw, Pierre Bagnaninchi, Richard Weller, Andrew McLeod FRSB, Baljean Dhillon
Ultraviolet Radiation (UVR) has a well-established causative influence within the aetiology of conditions of the skin and the anterior segment of the eye. However, a grounded assessment of the role of UVR within conditions of the retina has been hampered by a historical lack of quantitative, and spectrally resolved, assessment of how UVR impacts upon the retina in terms congruent with contemporary
-
The endoplasmic reticulum: Homeostasis and crosstalk in retinal health and disease Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-12-12 Sarah X. Zhang, Josh J. Wang, Christopher R. Starr, Eun-Jin Lee, Sophia Park, Assylbek Zhylkibayev, Andy Medina, Jonathan H. Lin, Marina Gorbatyuk
The endoplasmic reticulum (ER) is the largest intracellular organelle carrying out a broad range of important cellular functions including protein biosynthesis, folding, and trafficking, lipid and sterol biosynthesis, carbohydrate metabolism, and calcium storage and gated release. In addition, the ER makes close contact with multiple intracellular organelles such as mitochondria and the plasma membrane
-
IOP and glaucoma damage: The essential role of optic nerve head and retinal mechanosensors Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-12-16 Ian Pitha, Liya Du, Thao D. Nguyen, Harry Quigley
There are many unanswered questions on the relation of intraocular pressure to glaucoma development and progression. IOP itself cannot be distilled to a single, unifying value, because IOP level varies over time, differs depending on ocular location, and can be affected by method of measurement. Ultimately, IOP level creates mechanical strain that affects axonal function at the optic nerve head which
-
Neonatal sepsis as a cause of retinopathy of prematurity: An etiological explanation Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-11-19 Olaf Dammann, Brian K. Stansfield
Retinopathy of prematurity (ROP) is a complex neonatal disorder with multiple contributing factors. In this paper we have mounted the evidence in support of the proposal that neonatal sepsis meets all requirements for being a cause of ROP (not a condition, mechanism, or even innocent bystander) by means of initiating the early stages of the pathomechanism of ROP occurrence, systemic inflammation. We
-
-
Optical coherence tomography in the management of diabetic macular oedema Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-11-07 Simon KH. Szeto, Timothy YY. Lai, Stela Vujosevic, Jennifer K. Sun, SriniVas R. Sadda, Gavin Tan, Sobha Sivaprasad, Tien Y. Wong, Carol Y. Cheung
Diabetic macular oedema (DMO) is the major cause of visual impairment in people with diabetes. Optical coherence tomography (OCT) is now the most widely used modality to assess presence and severity of DMO. DMO is currently broadly classified based on the involvement to the central 1 mm of the macula into non-centre or centre involved DMO (CI-DMO) and DMO can occur with or without visual acuity (VA)
-
Assessment of angle closure disease in the age of artificial intelligence: A review Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-11-03 Zhi Da Soh, Mingrui Tan, Monisha Esther Nongpiur, Benjamin Yixing Xu, David Friedman, Xiulan Zhang, Christopher Leung, Yong Liu, Victor Koh, Tin Aung, Ching-Yu Cheng
Primary angle closure glaucoma is a visually debilitating disease that is under-detected worldwide. Many of the challenges in managing primary angle closure disease (PACD) are related to the lack of convenient and precise tools for clinic-based disease assessment and monitoring. Artificial intelligence (AI)- assisted tools to detect and assess PACD have proliferated in recent years with encouraging
-
From randomised controlled trials to real-world data: Clinical evidence to guide management of diabetic macular oedema Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-10-26 Pierre-Henry Gabrielle, Hemal Mehta, Daniel Barthelmes, Vincent Daien, Vuong Nguyen, Mark C. Gillies, Catherine P. Creuzot-Garcher
Randomised clinical trials (RCTs) are generally considered the gold-standard for providing scientific evidence for treatments' effectiveness and safety but their findings may not always be generalisable to the broader population treated in routine clinical practice. RCTs include highly selected patient populations that fit specific inclusion and exclusion criteria. Although they may have a lower level
-
Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-10-12 Taraprasad Das, Joveeta Joseph, Matthew P. Simunovic, Andrzej Grzybowski, Kuan-Jen Chen, Vivek Pravin Dave, Savitri Sharma, Patrick Staropoli, Harry Flynn
Infectious endophthalmitis is a severe intraocular infection caused by bacteria, or less commonly by fungi. It can occur after penetrating eye procedures, trauma, or the spread of infection from contiguous structures or via emboli from distant organs. Because of the time-critical nature of the treatment, endophthalmitis is treated with the clinical diagnosis and modified by the microbiological report
-
Neurovascular dysfunction in glaucoma Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-09-30 Luis Alarcon-Martinez, Yukihiro Shiga, Deborah Villafranca-Baughman, Jorge L. Cueva Vargas, Isaac A. Vidal Paredes, Heberto Quintero, Brad Fortune, Helen Danesh-Meyer, Adriana Di Polo
Retinal ganglion cells, the neurons that die in glaucoma, are endowed with a high metabolism requiring optimal provision of oxygen and nutrients to sustain their activity. The timely regulation of blood flow is, therefore, essential to supply firing neurons in active areas with the oxygen and glucose they need for energy. Many glaucoma patients suffer from vascular deficits including reduced blood
-
Risk factors, clinical features and treatment of Behçet's disease uveitis Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-09-19 Zhenyu Zhong, Guannan Su, Peizeng Yang
Behçet's disease is a systemic vasculitis frequently associated with intraocular inflammation. Recent findings identified independent clinical clusters in Behçet's disease, each involving distinct combinations of affected organs. Ocular Behçet's disease, mainly manifested as uveitis, is characterized as an independent cluster with a low likelihood of association with other system involvements, such
-
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-08-21 Sandra Hoyek, Natasha F.S. da Cruz, Nimesh A. Patel, Hasenin Al-Khersan, Kenneth C. Fan, Audina M. Berrocal
Retinopathy of prematurity (ROP) is a leading cause of preventable vision loss in preterm infants. While appropriate screening is crucial for early identification and treatment of ROP, current screening guidelines remain limited by inter-examiner variability in screening modalities, absence of local protocol for ROP screening in some settings, a paucity of resources and an increased survival of younger
-
Latest advances in white spot syndromes: New findings and interpretations Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-08-12 Maria Vittoria Cicinelli, Prithvi Ramtohul, Alessandro Marchese, Francesco Bandello, K. Bailey Freund, Elisabetta Miserocchi, Lee M. Jampol
-
Optical coherence tomography angiography in diabetic retinopathy Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-07-26 Nadia K. Waheed, Richard B. Rosen, Yali Jia, Marion R. Munk, David Huang, Amani Fawzi, Victor Chong, Quan Dong Nguyen, Yasir Sepah, Elizabeth Pearce
There remain many unanswered questions on how to assess and treat the pathology and complications that arise from diabetic retinopathy (DR). Optical coherence tomography angiography (OCTA) is a novel and non-invasive three-dimensional imaging method that can visualize capillaries in all retinal layers. Numerous studies have confirmed that OCTA can identify early evidence of microvascular changes and
-
Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-07-15
Mitochondrial function is key to support metabolism and homeostasis in the retina, an organ that has one of the highest metabolic rates body-wide and is constantly exposed to photooxidative damage and external stressors. Mitophagy is the selective autophagic degradation of mitochondria within lysosomes, and can be triggered by distinct stimuli such as mitochondrial damage or hypoxia. Here, we review
-
Neville Osborne - Editor-in-Chief of Progress in Retinal and Eye Research for 40 years Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-07-19
Abstract not available
-
Female carriers of X-linked inherited retinal diseases – Genetics, diagnosis, and potential therapies Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-07-03 Sena A. Gocuk, Jasleen K. Jolly, Thomas L. Edwards, Lauren N. Ayton
Inherited retinal diseases (IRDs) are a group of heterogeneous conditions that cause progressive vision loss, typically due to monogenic mutations. Female carriers of X-linked IRDs have a single copy of the disease-causing gene, and therefore, may exhibit variable clinical signs that vary from near normal retina to severe disease and vision loss. The relationships between individual genetic mutations
-
Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO) Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-07-01 Mohammad Javed Ali
Primary acquired nasolacrimal duct obstruction, or PANDO, is a common adult lacrimal drainage disorder. The current treatment modality of dacryocystorhinostomy to bypass the obstructed nasolacrimal duct has excellent outcomes. However, the understanding of the disease etiopathogenesis needs to be revisited. There are not many studies that specifically assessed any hypothesis or ones that convincingly
-
Posterior corneoscleral limbus: Architecture, stem cells, and clinical implications Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-06-29 Gary Hin-Fai Yam, Shaohua Pi, Yiqin Du, Jodhbir S. Mehta
The limbus is a transition from the cornea to conjunctiva and sclera. In human eyes, this thin strip has a rich variation of tissue structures and composition, typifying a change from scleral irregularity and opacity to corneal regularity and transparency; a variation from richly vascularized conjunctiva and sclera to avascular cornea; the neural passage and drainage of aqueous humor. The limbal stroma
-
Familial normal tension glaucoma genetics Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-06-22 Austin R. Fox, John H. Fingert
Glaucoma is defined by characteristic optic nerve damage and corresponding visual field defects and is the leading cause of irreversible blindness in the world. Elevated intraocular pressure (IOP) is a strong risk factor for developing glaucoma. However, glaucoma can occur at any IOP. Normal tension glaucoma (NTG) arises with IOPs that are within what has been defined as a normal range, i.e., 21 mm
-
The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-05-25 Ikhwanuliman Putera, Benjamin Schrijver, Josianne C.E.M. ten Berge, Vishali Gupta, Rina La Distia Nora, Rupesh Agrawal, P. Martin van Hagen, Saskia M. Rombach, Willem A. Dik
Tubercular uveitis (TB-uveitis) remains a conundrum in the uveitis field, which is mainly related to the diverse clinical phenotypes of TB-uveitis. Moreover, it remains difficult to differentiate whether () is present in the ocular tissues, elicits a heightened immune response without invasion in ocular tissues, or even induces an anti-retinal autoimmune response. Gaps in the immuno-pathological knowledge
-
Myocilin misfolding and glaucoma: A 20-year update Prog. Retin. Eye. Res. (IF 18.6) Pub Date : 2023-05-20 Emily G. Saccuzzo, Hannah A. Youngblood, Raquel L. Lieberman
Mutations in the gene account for approximately 5% of cases of primary open angle glaucoma (POAG). encodes for the protein myocilin, a multimeric secreted glycoprotein composed of N-terminal coiled-coil (CC) and leucine zipper (LZ) domains that are connected via a disordered linker to a 30 kDa olfactomedin (OLF) domain. More than 90% of glaucoma-causing mutations are localized to the OLF domain. While